(Q28570995)

31 January 2017

title

Omega-3 fatty acid supplementation attenuates oxidative stress, inflammation, and tubulointerstitial fibrosis in the remnant kidney (English)

1 reference

31 January 2017

0 references

0 references

Won Suk An

1

1 reference

31 January 2017

Hyun Ju Kim

series ordinal

2

1 reference

31 January 2017

Kyu-Hyang Cho

series ordinal

3

1 reference

31 January 2017

Nosratola D. Vaziri

series ordinal

4

1 reference

31 January 2017

publication date

1 October 2009

1 reference

American Journal of Physiology - Renal Physiology

31 January 2017

published in

1 reference

31 January 2017

volume

297

1 reference

31 January 2017

issue

4

1 reference

31 January 2017

page(s)

F895–903

1 reference

Transforming growth factor beta in tissue fibrosis

31 January 2017

cites work

1 reference

https://api.crossref.org/works/10.1152%2FAJPRENAL.00217.2009

The role of tubular epithelial-mesenchymal transition in progressive kidney disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPRENAL.00217.2009

Niacin ameliorates oxidative stress, inflammation, proteinuria, and hypertension in rats with chronic renal failure

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPRENAL.00217.2009

Signaling pathways modulated by fish oil in salt-sensitive hypertension

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPRENAL.00217.2009

Arachidonate 5-lipoxygenase promoter genotype, dietary arachidonic acid, and atherosclerosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPRENAL.00217.2009

Cyclooxygenase-2 (COX-2) inhibition limits abnormal COX-2 expression and progressive injury in the remnant kidney

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPRENAL.00217.2009

Chronic inhibition of nuclear factor-kappaB attenuates renal injury in the 5/6 renal ablation model.

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPRENAL.00217.2009

Renal expression of COX-2, ANG II, and AT1 receptor in remnant kidney: strong renoprotection by therapy with losartan and a nonsteroidal anti-inflammatory

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPRENAL.00217.2009

Connective tissue growth factor: potential role in glomerulosclerosis and tubulointerstitial fibrosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPRENAL.00217.2009

Eicosapentaenoic acid ameliorates diabetic nephropathy of type 2 diabetic KKAy/Ta mice: involvement of MCP-1 suppression and decreased ERK1/2 and p38 phosphorylation

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPRENAL.00217.2009

Physiologic and pathophysiologic roles of lipid mediators in the kidney

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPRENAL.00217.2009

Omega-3 fatty acids in cardiac biopsies from heart transplantation patients: correlation with erythrocytes and response to supplementation

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPRENAL.00217.2009

Regulation of TGF-beta family signaling by E3 ubiquitin ligases

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPRENAL.00217.2009

Tubular epithelial-myofibroblast transdifferentiation mechanisms in proximal tubule cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPRENAL.00217.2009

Clinical prevention of sudden cardiac death by n-3 polyunsaturated fatty acids and mechanism of prevention of arrhythmias by n-3 fish oils

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPRENAL.00217.2009

Advanced glycation end products induce tubular epithelial-myofibroblast transition through the RAGE-ERK1/2 MAP kinase signaling pathway

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPRENAL.00217.2009

Influence of highly purified eicosapentaenoic acid ethyl ester on insulin resistance in the Otsuka Long-Evans Tokushima Fatty rat, a model of spontaneous non-insulin-dependent diabetes mellitus.

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPRENAL.00217.2009

Melatonin ameliorates oxidative stress, inflammation, proteinuria, and progression of renal damage in rats with renal mass reduction.

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPRENAL.00217.2009

Mechanisms of progression and regression of renal lesions of chronic nephropathies and diabetes

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPRENAL.00217.2009

Mycophenolate mofetil ameliorates nephropathy in the obese Zucker rat.

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPRENAL.00217.2009

TGF-beta signaling in vascular fibrosis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPRENAL.00217.2009

Targeted disruption of TGF-β1/Smad3 signaling protects against renal tubulointerstitial fibrosis induced by unilateral ureteral obstruction

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPRENAL.00217.2009

Intra-renal angiotensin II/AT1 receptor, oxidative stress, inflammation, and progressive injury in renal mass reduction

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPRENAL.00217.2009

Oxidative stress and dysregulation of superoxide dismutase and NADPH oxidase in renal insufficiency

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPRENAL.00217.2009

Transforming growth factor-beta and Smad signalling in kidney diseases.

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPRENAL.00217.2009

Effects of eicosapentaenoic acid on the early stage of type 2 diabetic nephropathy in KKA(y)/Ta mice: involvement of anti-inflammation and antioxidative stress.

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPRENAL.00217.2009